| Claudin-5: gatekeeper of neurological function C Greene, N Hanley, M Campbell Fluids and Barriers of the CNS 16, 1-15, 2019 | 485 | 2019 |
| Blood-brain barrier regulation in psychiatric disorders J Kealy, C Greene, M Campbell Neuroscience letters 726, 133664, 2020 | 275 | 2020 |
| Tight junction modulation of the blood brain barrier: CNS delivery of small molecules C Greene, M Campbell Tissue barriers 4 (1), e1138017, 2016 | 256 | 2016 |
| Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia C Greene, J Kealy, MM Humphries, Y Gong, J Hou, N Hudson, ... Molecular psychiatry 23 (11), 2156-2166, 2018 | 212 | 2018 |
| Blood–brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment C Greene, R Connolly, D Brennan, A Laffan, E O’Keeffe, L Zaporojan, ... Nature Neuroscience 27 (3), 421-432, 2024 | 159 | 2024 |
| Blood-brain barrier associated tight junction disruption is a hallmark feature of major psychiatric disorders C Greene, N Hanley, M Campbell Translational psychiatry 10 (1), 373, 2020 | 156 | 2020 |
| Dynamic Blood–Brain Barrier Regulation in Mild Traumatic Brain Injury E O'Keeffe, E Kelly, Y Liu, C Giordano, E Wallace, M Hynes, S Tiernan, ... Journal of neurotrauma 37 (2), 347-356, 2020 | 148 | 2020 |
| Microvascular stabilization via blood-brain barrier regulation prevents seizure activity C Greene, N Hanley, CR Reschke, A Reddy, MA Mäe, R Connolly, ... Nature Communications 13 (1), 2003, 2022 | 86 | 2022 |
| Reversibly Modulating the Blood–Brain Barrier by Laser Stimulation of Molecular-Targeted Nanoparticles X Li, V Vemireddy, Q Cai, H Xiong, P Kang, X Li, M Giannotta, ... Nano Letters 21 (22), 9805-9815, 2021 | 79 | 2021 |
| The CLDN5 gene at the blood-brain barrier in health and disease Y Hashimoto, C Greene, A Munnich, M Campbell Fluids and Barriers of the CNS 20 (1), 22, 2023 | 61 | 2023 |
| Dysregulated claudin-5 cycling in the inner retina causes retinal pigment epithelial cell atrophy N Hudson, L Celkova, A Hopkins, C Greene, F Storti, E Ozaki, E Fahey, ... JCI insight 4 (15), 2019 | 61 | 2019 |
| Toll-like Receptor 2 Facilitates Oxidative Damage-Induced Retinal Degeneration K Mulfaul, E Ozaki, N Fernando, K Brennan, KR Chirco, E Connolly, ... Cell Reports 30 (7), 2209-2224. e5, 2020 | 56 | 2020 |
| Attenuated CSF‐1R signalling drives cerebrovascular pathology C Delaney, M Farrell, CP Doherty, K Brennan, E O’Keeffe, C Greene, ... EMBO molecular medicine 13 (2), e12889, 2021 | 50 | 2021 |
| Blood-brain barrier dysfunction in a boxer with chronic traumatic encephalopathy and schizophrenia M Farrell, S Aherne, S O’Riordan, E O’Keeffe, C Greene, M Campbell Clinical neuropathology 38 (2), 51, 2019 | 41 | 2019 |
| Embryonic rat vascular smooth muscle cells revisited-a model for neonatal, neointimal SMC or differentiated vascular stem cells? E Kennedy, R Hakimjavadi, C Greene, CJ Mooney, E Fitzpatrick, ... Vascular Cell 6, 1-13, 2014 | 32 | 2014 |
| Systemic delivery of antagomirs during blood-brain barrier disruption is disease-modifying in experimental epilepsy CR Reschke, LFA Silva, VR Vangoor, M Rosso, B David, BL Cavanagh, ... Molecular Therapy 29 (6), 2041-2052, 2021 | 30 | 2021 |
| Claudin-5: gatekeeper of neurological function. Fluids Barriers CNS. 2019; 16 (1): 3 C Greene, N Hanley, M Campbell Epub 2019/01/30. doi: 10.1186/s12987-019-0123-z. PubMed PMID: 30691500, 2019 | 16 | 2019 |
| SARM1 promotes photoreceptor degeneration in an oxidative stress model of retinal degeneration L Gibbons, E Ozaki, C Greene, A Trappe, M Carty, JA Coppinger, ... Frontiers in Neuroscience 16, 852114, 2022 | 8 | 2022 |
| Methamphetamine enhances caveolar transport of therapeutic agents across the rodent blood-brain barrier JH Chang, C Greene, K Frudd, LA Dos Santos, C Futter, BJ Nichols, ... Cell Reports Medicine 3 (1), 2022 | 6 | 2022 |
| Blood-brain barrier disruption in Long COVID-associated cognitive impairment M Campbell, C Greene, R Connolly, D Brennan, A Laffan, E O'Keeffe, ... Research Square, 2022 | 4 | 2022 |
